Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CT-PET for Prediction of Histopathologic Response, Nodal Status and Oncologic Outcome Following Neoadjuvant Chemoradiation for Esophageal Cancer

NCT02385604 is registered in ClinicalTrials.gov with St. James's Hospital, Ireland as lead sponsor.

NCT NCT02385604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02385604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CT-PET for Prediction of Histopathologic Response, Nodal Status and Oncologic Outcome Following Neoadjuvant Chemoradiation for Esophageal Cancer
Lead sponsor
St. James's Hospital, Ireland
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
January 31, 2016
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasms